Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin
- PMID: 6150140
- DOI: 10.1016/s0140-6736(84)91506-x
Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin
Abstract
Acute non-A, non-B hepatitis developed in twelve patients with primary hypogammaglobulinaemia during treatment with intravenous gammaglobulin prepared by Cohn fractionation of pooled plasma. The illness was clinically and histologically identical to the short-incubation non-A, non-B, hepatitis observed in haemophilic patients receiving factor VIII concentrates. Most of the patients were symptomless, but 10 months after onset ten of the twelve still had abnormal liver function. The occurrence of non-A, non-B hepatitis in agammaglobulinaemics indicates that humoral mechanisms are not essential for production of hepatocyte necrosis in this infection. This outbreak emphasises the need for a screening test to identify the agent in blood products, and shows that Cohn fractionation of plasma does not always inactivate the agent. Furthermore, the finding that the virus can be transmitted in IgG concentrates suggests either that the general population has a very low level of antibodies to the putative virus or that such antibodies are not virus-neutralising.
Similar articles
-
Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferon.Acta Med Scand. 1987;221(4):413-5. doi: 10.1111/j.0954-6820.1987.tb03365.x. Acta Med Scand. 1987. PMID: 3111178
-
Infection with hepatitis G virus among recipients of plasma products.Lancet. 1996 Nov 16;348(9038):1352-5. doi: 10.1016/s0140-6736(96)04041-x. Lancet. 1996. PMID: 8918279
-
Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency.Am J Med. 1988 Jan;84(1):107-11. doi: 10.1016/0002-9343(88)90016-2. Am J Med. 1988. PMID: 3122562
-
Immunoglobulin preparation: safe from virus transmission?Vox Sang. 1989;57(1):1-3. doi: 10.1111/j.1423-0410.1989.tb04974.x. Vox Sang. 1989. PMID: 2508323 Review.
-
Clinical experience with the viral safety of immunoglobulins.Blood Coagul Fibrinolysis. 1994 Dec;5 Suppl 3:S31-4; discussion S35. doi: 10.1097/00001721-199412003-00008. Blood Coagul Fibrinolysis. 1994. PMID: 7749046 Review.
Cited by
-
Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.CMAJ. 1992 Jan 15;146(2):121-4. CMAJ. 1992. PMID: 1735037 Free PMC article. No abstract available.
-
New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.Infection. 1990 Sep-Oct;18(5):314-24. doi: 10.1007/BF01647018. Infection. 1990. PMID: 2125980 Review. No abstract available.
-
Non-A, non-B hepatitis: dead ends or new horizons?Br Med J (Clin Res Ed). 1987 Oct 17;295(6604):946-8. doi: 10.1136/bmj.295.6604.946. Br Med J (Clin Res Ed). 1987. PMID: 3119121 Free PMC article. Review. No abstract available.
-
The nontreatment of childhood idiopathic thrombocytopenic purpura.Eur J Pediatr. 1987 Mar;146(2):107-12. doi: 10.1007/BF02343213. Eur J Pediatr. 1987. PMID: 3552690 Review.
-
Role of retroviruses in acquired hypogammaglobulinaemia.Clin Exp Immunol. 1988 Nov;74(2):177-81. Clin Exp Immunol. 1988. PMID: 2465107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical